Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. - Wikidata - wikimedia - TriplyDB

Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106.

Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106.

http://www.wikidata.org/entity/Q43115816

about

Neuroinflammation and psychiatric illness Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials Linking Activation of Microglia and Peripheral Monocytic Cells to the Pathophysiology of Psychiatric Disorders The role of inflammation in schizophrenia Neuron-glia interaction as a possible glue to translate the mind-brain gap: a novel multi-dimensional approach toward psychology and psychiatry The cytokine model of schizophrenia: emerging therapeutic strategies Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and Microglia In vivo imaging of neuroinflammation in schizophrenia Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases Molecular imaging of microglia/macrophages in the brain.Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study.Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.Radiosynthesis, In Vivo Biological Evaluation, and Imaging of Brain Lesions with [123I]-CLINME, a New SPECT Tracer for the Translocator Protein Microglial activation and progressive brain changes in schizophrenia.Are microglia minding us? Digging up the unconscious mind-brain relationship from a neuropsychoanalytic approach.Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma.Regulation of astrocyte glutamine synthetase in epilepsy Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder.Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.The neurobiology and treatment of first-episode schizophrenia.Maternal immune activation and abnormal brain development across CNS disorders.Microglial intracellular Ca(2+) signaling as a target of antipsychotic actions for the treatment of schizophrenia.Glia-related genes and their contribution to schizophrenia.Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA.Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence.Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia.Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [(11)C](R)-PK11195 positron emission tomography study.Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA.In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis.Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders.Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.

P2860

Q21245244-58AFBB43-C2BF-471A-9E80-36648042A6BF Q26741541-0870F225-3989-4622-AC88-8DFDE61A46A4 Q26745417-0934B099-D19A-438D-835F-2E9CADDB632C Q26779719-B978EA0F-1070-4934-B2DB-B3163B94EBB9 Q26825959-4AC38927-5AA4-4BD3-BCD7-CEAB0A79B0A0 Q26865996-A7577311-CDD3-4345-8EAF-FFA87A88CA01 Q26999061-05581C7F-E2A5-4593-B3AA-327F0A6A0E1F Q28077391-6E514E63-9046-4C68-A98D-4A5954577E8E Q30236016-616A0048-699F-4A77-8C2A-88DAD01D6C9B Q30452038-A66161DD-DD63-40BE-90AB-2C5827773819 Q30966978-9243B00A-0D3D-4AA9-A345-7B07BA0C9221 Q33624586-4EB245E6-9B4C-457A-8ADC-A75560B62185 Q34276818-00184BB6-63D3-4460-B7FD-5BD67C1150ED Q34315675-D00276BE-881A-4803-9ED7-3C6E2EF35088 Q34680956-B60F189D-C0D8-4B85-8519-E962AC040574 Q34701163-D1AD47CF-22DE-4AD7-BA64-106E3936BED4 Q35603078-4A7B04EA-9BB0-4B41-8177-6DDCE522D10E Q35833477-BC9FAB96-0018-45BD-A741-C59A7471FDD1 Q36546971-9A58C408-17D9-4250-8A59-4FB396C1207A Q36634686-9440DD04-891F-4A2D-AC2A-1CCF2326C468 Q36766806-74175B1F-F58B-4714-BEDA-94BC4754613F Q36915357-85458A93-3D1B-45BC-AC62-8FB33C348B88 Q37303011-74DBFC8D-CBEA-45DC-A299-F270086C8CD0 Q37621319-11B9C5C9-52A3-4AB7-B108-91D09241F2E3 Q37879217-3F5EA7CA-DB39-4019-BA38-EF5BC58AA066 Q38232366-E87E65B9-2A89-4489-A45A-FA083425147A Q38259759-3770F081-DE47-4887-A5CB-56664A2197D2 Q38270172-8CE4B207-AD5B-436F-AF90-6B335E973EBE Q38373219-B1E295CF-5171-4176-AB2E-046A0F85D008 Q38730353-291D1DB5-F79C-4F48-B2A7-BBDC58549F7B Q38739624-4332B7BA-1E0B-41E9-A3ED-662CA79C6498 Q38809444-4A9FA852-1012-4A49-9DDB-8B1A1665FD59 Q38901529-9D8764F6-EA72-4350-BB49-3980F2325031 Q39050960-B2AD2BCF-AE2E-4B42-8A2F-312FE1CFABB9 Q39057006-AD74C010-4626-4133-B2F6-B6FDFCBA251C Q39326557-E66D4B41-9208-4534-A278-BA611F39BDC2 Q39409090-581EB6CF-ACEE-4B5A-A0F3-9B53E812EE43 Q39415063-AAE27D4C-BCF7-4D43-9826-294C93E1A91C Q39458323-F1076A18-F0E5-4461-9085-3F76B04FAFCC Q40369760-17E166A4-676B-4488-91C9-9D9FD7C34152

P2860

Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106.

http://www.wikidata.org/entity/Q43115816

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Peripheral benzodiazepine rece ...... a PET study with [11C]DAA1106.

@en

Peripheral benzodiazepine rece ...... a PET study with [11C]DAA1106.

@nl

type

label

Peripheral benzodiazepine rece ...... a PET study with [11C]DAA1106.

@en

Peripheral benzodiazepine rece ...... a PET study with [11C]DAA1106.

@nl

prefLabel

Peripheral benzodiazepine rece ...... a PET study with [11C]DAA1106.

@en

Peripheral benzodiazepine rece ...... a PET study with [11C]DAA1106.

@nl

P1433

Q43115816-318E4311-70BD-4949-B6B0-584E7CB2E04C

P1476

Q43115816-23544BF3-48EE-481F-9384-8E979F44EE6A

P2093

Q43115816-399B52E8-D08C-4686-A5A9-2DC918E9D19B

Q43115816-4F2690B2-E0C1-425C-8E57-49BD28E9C318

Q43115816-6DBB21D3-A3B8-4923-9B25-871774B929B1

Q43115816-71E35DCD-F563-4127-8EE7-B86E6C8EC416

Q43115816-89B72524-F344-401F-B524-5A48D4E26832

Q43115816-8DC1536E-1482-477F-833D-065473BB0D82

Q43115816-B8D1FDDD-F3B9-4D79-A667-E8E6B35BDE91

Q43115816-ECFC77DA-ECE2-4D64-854D-AD68EC605C7C

P2860

Q43115816-1310877F-B4B4-48DF-A294-90E289ACDBA7

Q43115816-20F523FE-F847-40D8-A964-E7091CFA555B

Q43115816-28DC191C-A444-482F-A311-A803E9192758

Q43115816-2AC8769D-75C8-4A21-93CB-43D1348BCC68

Q43115816-2C4A3449-9A21-4C6F-B6B0-1D9301CD13A4

Q43115816-3D0DAD7C-5DAC-48AB-9FB3-8C4F47FBCDFE

Q43115816-3FD90416-27B5-4888-9184-4314C386B543

Q43115816-47730AAB-58D1-4AD0-B5D4-F42539EA2F09

Q43115816-4811BB8D-7C2D-4E79-96F0-4067A8131723

Q43115816-4E44B45F-CE10-4B5A-B5F1-135B4A525D78

P304

Q43115816-0B4FC08C-E141-4F53-9908-022428EFCBAC

P31

Q43115816-58A7D8AC-14A1-4ED0-831F-3CD4EE429FDF

P356

Q43115816-E75076B6-7E87-4F9B-BFB1-DC7912CE2C11

P433

Q43115816-4C047E54-8C8B-4C56-ACB8-3357E12B2E43

P478

Q43115816-6F4BA8A0-9896-45A8-AE89-34787C188C70

P577

Q43115816-3599CE5B-0922-4905-8BD4-A5DC647D046B

P698

Q43115816-8562C29A-D267-4441-B9F9-E4D629C40B75

P921

Q43115816-E4CBD4F5-1468-4BC0-AA4D-B4E065AA9E5D

P356

S1461145710000313

P1433

The International Journal of Neuropsychopharmacology

P1476

Peripheral benzodiazepine rece ...... a PET study with [11C]DAA1106.

@en

P2093

Akihiro Takano

http://www.w3.org/2001/XMLSchema#string

Amane Tateno

http://www.w3.org/2001/XMLSchema#string

Hidehiko Takahashi

http://www.w3.org/2001/XMLSchema#string

Hiroshi Ito

http://www.w3.org/2001/XMLSchema#string

Ryohei Matsumoto

http://www.w3.org/2001/XMLSchema#string

Ryosuke Arakawa

http://www.w3.org/2001/XMLSchema#string

Tetsuya Suhara

http://www.w3.org/2001/XMLSchema#string

Yoshiro Okubo

http://www.w3.org/2001/XMLSchema#string

P2860

Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies

A review of MRI findings in schizophrenia

Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia

The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production

The positive and negative syndrome scale (PANSS) for schizophrenia

Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro

Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study.

Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106.

P-glycoprotein activity and biological response.

Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines.

P304

943-950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1461145710000313

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20350336

http://www.w3.org/2001/XMLSchema#string

P921